David N. Cook
Chief Tech/Sci/R&D Officer bij FORMA THERAPEUTICS HOLDINGS, INC.
Profiel
David N.
Cook was the founder of Anza Therapeutics, Inc. (founded in 2007) and held the title of Chief Executive Officer from 2010 to 2011.
He is currently the Chief Executive Officer & Director at Edgewood Oncology, Inc. (since 2023), Director at Global HIV Vaccine Enterprise (since 2011), Director at Novome Biotechnologies, Inc. (since 2021), Director at X-Biotix Therapeutics, Inc., and Chief Scientific Officer & Senior Vice President at Forma Therapeutics Holdings, Inc. (since 2020).
In his former positions, Dr. Cook served as the Senior Vice President-Research & Development at Cerus Corp.
(from 2001 to 2007) and Eligix, Inc. (from 1999 to 2001), Chief Operating Officer at International AIDS Vaccine Initiative, Inc. (from 2010 to 2012), and Head-Business Advocacy at Bio Ventures for Global Health (from 2009 to 2010).
He also held the position of Chief Scientific Officer & Executive VP-Research at Seres Therapeutics, Inc. (from 2012 to 2019).
Dr. Cook obtained a doctorate degree from the University of California, Berkeley and an undergraduate degree from Harvard College.
Actieve functies van David N. Cook
| Bedrijven | Functie | Begin |
|---|---|---|
| FORMA THERAPEUTICS HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | 01-04-2020 |
Global HIV Vaccine Enterprise
 Global HIV Vaccine Enterprise Miscellaneous Commercial ServicesCommercial Services Global HIV Vaccine Enterprise engages in the development of preventive HIV vaccines. The company was founded in June 2003 and is headquartered in New York, NY. | Director/Board Member | 01-06-2011 |
X-Biotix Therapeutics, Inc.
 X-Biotix Therapeutics, Inc. BiotechnologyHealth Technology X-Biotix Therapeutics, Inc. is a biotechnology company focused on the discovery and development, which focuses on the novel small molecule antibiotics that target resistant gram-negative bacteria. The company was founded by Ramani Varanasi in 2016 and is headquartered in Waltham, MA. | Director/Board Member | - |
Novome Biotechnologies, Inc.
 Novome Biotechnologies, Inc. BiotechnologyHealth Technology Novome Biotechnologies, Inc. operates as a biotechnology company focused on engineering defined activities into the human gut microbiota to treat chronic diseases. The company was founded by William DeLoache, Weston Whitaker, Liz Shepherd and Zachary Russ in 2016 and is headquartered in South San Francisco, CA. | Director/Board Member | 26-05-2021 |
Eerdere bekende functies van David N. Cook
| Bedrijven | Functie | Einde |
|---|---|---|
| SERES THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01-03-2019 |
International AIDS Vaccine Initiative, Inc.
 International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | Chief Operating Officer | 01-10-2012 |
| Bio Ventures for Global Health | Corporate Officer/Principal | 01-02-2010 |
| CERUS CORPORATION | Chief Tech/Sci/R&D Officer | 01-11-2007 |
Eligix, Inc.
 Eligix, Inc. Medical/Nursing ServicesHealth Services Eligix, Inc. develops and distributes medicines. It also offers cellular transplantation and immune therapies to enhance human immune response to cancers and infectious diseases. The company is located in Medford, MA | Chief Tech/Sci/R&D Officer | 01-08-2001 |
Opleiding van David N. Cook
| University of California, Berkeley | Doctorate Degree |
| Harvard College | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| CERUS CORPORATION | Health Technology |
| SERES THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 8 |
|---|---|
Eligix, Inc.
Eligix, Inc. Medical/Nursing ServicesHealth Services Eligix, Inc. develops and distributes medicines. It also offers cellular transplantation and immune therapies to enhance human immune response to cancers and infectious diseases. The company is located in Medford, MA | Health Services |
International AIDS Vaccine Initiative, Inc.
International AIDS Vaccine Initiative, Inc. Pharmaceuticals: MajorHealth Technology International AIDS Vaccine Initiative, Inc. researches and develops to prevent HIV infection and AIDS. It researches and develops vaccine candidates, conducts policy analyses, and serves as an advocate for the field with offices in Africa, India, and Europe. The firm's HIV research and development focuses on three strategies: the design of vaccine immunogens capable of inducing specialized proteins known as broadly neutralizing antibodies, the optimization and development of these antibodies as prevention products, and the development of replicating viral vectors and mRNA. The company was founded in 1996 by Seth Berkley and Lee C. Smith and is headquartered in New York, NY. | Health Technology |
Forma Therapeutics Holdings, Inc.
 Forma Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology Forma Therapeutics Holdings, Inc. is a clinical-stage biopharmaceutical company. engages in the research, development and commercialization of novel therapeutics for the treatment of hematologic diseases and cancers. Its product pipeline consists of FT-4202 for the treatment of sickle cell disease and other hemoglobinopathies, and FT-7051 for the treatment of metastatic castration-resistant prostate cancer. The company was founded by Michael A. Foley in December 2011 and is headquartered in Watertown, MA. | Health Technology |
| Bio Ventures for Global Health | |
Anza Therapeutics, Inc.
 Anza Therapeutics, Inc. Medical SpecialtiesHealth Technology Anza Therapeutics, Inc. develops products in the fields of cancer and infectious diseases. It also develops immunotherapy for infectious diseases, therapeutic vaccines for treating cancers that over-express Mesothelin and for treating people infected with the hepatitis C virus (HCV). The company was founded in 2007 and is headquartered in Concord, CA. | Health Technology |
Global HIV Vaccine Enterprise
Global HIV Vaccine Enterprise Miscellaneous Commercial ServicesCommercial Services Global HIV Vaccine Enterprise engages in the development of preventive HIV vaccines. The company was founded in June 2003 and is headquartered in New York, NY. | Commercial Services |
Novome Biotechnologies, Inc.
Novome Biotechnologies, Inc. BiotechnologyHealth Technology Novome Biotechnologies, Inc. operates as a biotechnology company focused on engineering defined activities into the human gut microbiota to treat chronic diseases. The company was founded by William DeLoache, Weston Whitaker, Liz Shepherd and Zachary Russ in 2016 and is headquartered in South San Francisco, CA. | Health Technology |
X-Biotix Therapeutics, Inc.
X-Biotix Therapeutics, Inc. BiotechnologyHealth Technology X-Biotix Therapeutics, Inc. is a biotechnology company focused on the discovery and development, which focuses on the novel small molecule antibiotics that target resistant gram-negative bacteria. The company was founded by Ramani Varanasi in 2016 and is headquartered in Waltham, MA. | Health Technology |
